Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Genmab A (GMAB) Income from Continuing Operations (2024 - 2025)

Historic Income from Continuing Operations for Genmab A (GMAB) over the last 2 years, with Q4 2025 value amounting to -$1.1 billion.

  • Genmab A's Income from Continuing Operations fell 32224.35% to -$1.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1204.0, marking a year-over-year decrease of 9999.99%. This contributed to the annual value of -$241.0 million for FY2025, which is 12127.09% down from last year.
  • Genmab A's Income from Continuing Operations amounted to -$1.1 billion in Q4 2025, which was down 32224.35% from $482.0 million recorded in Q3 2025.
  • Over the past 5 years, Genmab A's Income from Continuing Operations peaked at $517.0 million during Q4 2024, and registered a low of -$1.1 billion during Q4 2025.